InnovationRx: Venture Investments Into Biopharma And Medtech Reverse 2-Year Slide

Quick Summary:

Under the terms of the agreement, Novartis will make a $150 million upfront payment to Monte Rosa, plus up to $2.1 billion in milestone payments plus royalties.

Morgan’s analysts expect total investment to reach $21.5 billion for the year, surpassing last year’s $16.9 billion by nearly 30%.

On the medtech side, there was a total of $5.1 billion in venture investments in the sector last quarter.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: StartupsTechnology

Markets: United StatesOman

Topics: No-paywall Editors-pick Healthcare /science /healthcare Newsletter Editors' Pick Innovation No Paywall /innovation Venture Capital Premium Science Newsletter /venture-capital

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-30 @ 16:23:30 (1 days ago)

News Timezone: GMT -5:00

News Source URL: forbes.com

Language: English

Article Length: 24 words

Reading Time: 1 minutes read

Sentences: 48 lines

Sentence Length: 1 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Forbes

News ID: 23342155

View Article Analysis

About Forbes

Main Topics: StartupsTechnology

Official Website: forbes.com

Update Frequency: 59 posts per day

Year Established: 1917

Headquarters: United States

News Last Updated: 12 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #40

Publisher Details

Frequently Asked Questions